Our Mission
Home
Products
Investors
Leadership Team
News
More
Solutions to address severe allergy epidemics with the market’s first double-dosing injector to address patients at-risk of allergy induced anaphylaxis.
May 2021- Patent allowed granting AllerMED Pharmaceuticals proprietary rights for the only double-dosing injector.